BeStock  

欧加隆公司 OGN

美股市值排名 #2331药品制造-综合
$13.87 +$0.08 (+0.58%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $13.86 -0.07%
开盘$13.80
昨收$13.79
当日区间$13.78 – $13.87
成交量3.95M
市值$3.64B
市盈率(TTM)17.8
股息率0.58%

基本面

最新报告季度:Q3, ended Sep 2026

营收$1.57B-1.7% YoY
营业利润$365.00M+2.0% YoY
净利润$164.00M+2.5% YoY
摊薄每股收益$0.60-1.6% YoY
自由现金流$326.00M+118.8% YoY
经营现金流$370.00M

营收,近8个季度

$1.6BDec '24$1.5BMar '25$1.6BJun '25$1.6BSep '25$1.5BDec '25$1.5BMar '26$1.6BJun '26$1.6BSep '26

净利润,近8个季度

$109.0MDec '24$87.0MMar '25$145.0MJun '25$160.0MSep '25$-205.0MDec '25$146.0MMar '26$108.0MJun '26$164.0MSep '26

各季度摊薄每股收益

0.42Dec '240.33Mar '250.56Jun '250.61Sep '25-0.79Dec '250.55Mar '260.40Jun '260.60Sep '26

各季度自由现金流

$258.0MDec '24$-22.0MMar '25$181.0MJun '25$149.0MSep '25$76.0MDec '25$178.0MMar '26$31.0MJun '26$326.0MSep '26

年度营收

$6.5BFY20$6.3BFY21$6.2BFY22$6.3BFY23$6.4BFY24$6.2BFY25

盈利能力与资产负债表

毛利率52.7%
营业利润率19.0%
净利率3.4%
净资产收益率24.0%
资产收益率1.6%
投入资本回报率5.1%
流动比率1.95
负债/资产比率91.1%
现金及投资$1.46B
总负债$8.55B
净现金(净负债)-$7.10B
自由现金流/营收7.1%

营收构成

2026/Q2 季度

按业务线

  • Other$689.00M 47.6%
  • Nexplanon/Implanon NXT$230.00M 15.9%
  • Zetia$96.00M 6.6%
  • Atozet$80.00M 5.5%
  • Hadlima$79.00M 5.5%
  • Other Non-Opioid Pain, Bone and Dermatology$79.00M 5.5%
  • Arcoxia$69.00M 4.8%
  • Renflexis$65.00M 4.5%
  • Follistim AQ$59.00M 4.1%

利润表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
报告营业总收入 $1.57B $1.56B $1.46B $6.22B $1.51B
营业总收入 $1.57B $1.56B $1.46B $6.22B $1.51B
营业成本 $705.00M $711.00M $677.00M $2.90B $766.00M
毛利润 $869.00M $847.00M $783.00M $3.31B $741.00M
营业费用 $504.00M $524.00M $517.00M $2.09B $524.00M
销售及管理费用 $421.00M $434.00M $424.00M $1.72B $433.00M
研发费用 $83.00M $90.00M $93.00M $366.00M $91.00M
营业利润 $365.00M $323.00M $266.00M $1.23B $217.00M
非经营性利息净收入(支出) -$106.00M -$108.00M -$111.00M -$504.00M -$121.00M
非经营性利息支出 $106.00M $108.00M $111.00M $504.00M $121.00M
其他收入(支出) -$4.00M -$32.00M $58.00M -$297.00M -$244.00M
证券出售收益 -$6.00M -$2.00M -$7.00M -$14.00M -$2.00M
特殊收益(费用) $0.00 -$1.00M -$31.00M -$402.00M -$308.00M
-减:重组及并购费用 $0.00 $0.00 $31.00M $95.00M $7.00M
其他非经营性收入(支出) $2.00M -$29.00M $96.00M $119.00M $66.00M
税前利润 $255.00M $183.00M $213.00M $425.00M -$148.00M
税费 $91.00M $75.00M $67.00M $238.00M $57.00M
净利润 $164.00M $108.00M $146.00M $187.00M -$205.00M
持续经营利润 $164.00M $108.00M $146.00M $187.00M -$205.00M
归属母公司净利润 $164.00M $108.00M $146.00M $187.00M -$205.00M
归属普通股股东净利润 $164.00M $108.00M $146.00M $187.00M -$205.00M
基本每股收益 $0.62 $0.41 $0.55 $0.72 -$0.79
摊薄每股收益 $0.60 $0.40 $0.55 $0.72 -$0.79
每股股息 $0.02 $0.02 $0.02 $0.34 $0.02
-减:其他特殊支出 – $1.00M – $6.00M $0.00
-减:资本性资产减值 – – – $301.00M –

资产负债表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
总资产 $13.40B $13.18B $13.00B $12.87B $12.87B
流动资产合计 $5.37B $5.11B $4.93B $4.35B $4.35B
现金及现金等价物与短期投资 $1.46B $1.13B $1.12B $574.00M $574.00M
-现金及现金等价物 $1.46B $1.13B $1.12B $574.00M $574.00M
应收款 $1.48B $1.49B $1.38B $1.33B $1.33B
-应收账款 $1.48B $1.49B $1.38B $1.33B $1.33B
存货 $1.36B $1.35B $1.37B $1.41B $1.41B
其他流动资产 $1.08B $1.14B $1.06B $1.03B $1.03B
非流动资产合计 $8.03B $8.07B $8.06B $8.52B $8.52B
固定资产净值 $1.29B $1.28B $1.28B $1.30B $1.30B
商誉及其他无形资产 $5.22B $5.27B $5.25B $5.28B $5.28B
-商誉 $4.15B $4.15B $4.15B $4.15B $4.15B
-其他无形资产 $1.07B $1.11B $1.10B $1.13B $1.13B
其他非流动资产 $1.53B $1.52B $1.53B $1.93B $1.93B
负债合计 $12.21B $12.17B $12.09B $12.12B $12.12B
流动负债合计 $2.65B $2.62B $2.50B $2.39B $2.39B
应付款 $1.06B $1.14B $1.06B $1.04B $1.04B
-应付账款 $982.00M $1.05B $983.00M $952.00M $952.00M
-应付税款合计 $79.00M $84.00M $77.00M $85.00M $85.00M
一年内应计费用 $1.52B $1.41B $1.42B $1.34B $1.34B
短期债务及融资租赁负债 $69.00M $74.00M $16.00M $16.00M $16.00M
-一年内到期债务 $69.00M $74.00M $16.00M $16.00M $16.00M
非流动负债合计 $9.56B $9.56B $9.59B $9.73B $9.73B
长期债务及融资租赁负债 $8.49B $8.48B $8.55B $8.63B $8.63B
-长期债务 $8.49B $8.48B $8.55B $8.63B $8.63B
一年以上递延负债 $45.00M $51.00M $56.00M $57.00M $57.00M
其他非流动负债 $1.03B $1.03B $984.00M $1.01B $1.01B
股东权益合计 $1.19B $1.01B $903.00M $752.00M $752.00M
股东权益 $1.19B $1.01B $903.00M $752.00M $752.00M
股本 $3.00M $3.00M $3.00M $3.00M $3.00M
-普通股 $3.00M $3.00M $3.00M $3.00M $3.00M
资本公积 $218.00M $199.00M $186.00M $167.00M $167.00M
留存收益 $1.51B $1.35B $1.25B $1.11B $1.11B
不影响留存收益的损益 -$539.00M -$548.00M -$539.00M -$527.00M -$527.00M
-固定资产原值 – – – $2.54B $2.54B
-累计折旧 – – – -$1.24B -$1.24B
其他流动负债 – – – $2.00M $2.00M

现金流量表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
经营活动现金流 $370.00M $107.00M $225.00M $700.00M $141.00M
持续经营经营活动现金流净额 $370.00M $107.00M $225.00M $700.00M $141.00M
持续经营净利润 $164.00M $108.00M $146.00M $187.00M -$205.00M
持续经营损益 -$6.00M -$12.00M -$78.00M -$94.00M -$40.00M
折旧、折耗与摊销 $82.00M $80.00M $86.00M $361.00M $96.00M
递延税款 $13.00M $16.00M $3.00M $63.00M $30.00M
其他非现金项目 -$6.00M $15.00M $7.00M $43.00M -$14.00M
营运资金变动 $102.00M -$125.00M $42.00M -$247.00M -$34.00M
-应收款变动 $9.00M -$111.00M -$65.00M $79.00M $160.00M
-存货变动 -$12.00M -$15.00M -$9.00M -$13.00M $81.00M
-应付账款及应计费用变动 $45.00M $61.00M $123.00M -$420.00M -$307.00M
-其他流动资产变动 $55.00M -$76.00M -$15.00M -$32.00M $22.00M
-其他营运资金变动 $5.00M $16.00M $8.00M $139.00M $10.00M
投资活动现金流净额 -$44.00M -$76.00M $386.00M -$390.00M -$65.00M
持续经营投资活动现金流净额 -$44.00M -$76.00M $386.00M -$390.00M -$65.00M
资本支出 -$44.00M -$42.00M -$37.00M -$162.00M -$45.00M
固定资产购置及出售净额 $0.00 – – $1.00M $0.00
无形资产购置及出售净额 $0.00 -$34.00M -$10.00M -$154.00M -$20.00M
业务购买及出售净额 $0.00 $0.00 $433.00M -$75.00M $0.00
筹资活动现金流 -$5.00M -$12.00M -$38.00M -$561.00M -$187.00M
持续经营筹资活动现金流净额 -$5.00M -$12.00M -$38.00M -$561.00M -$187.00M
债务发行及偿还净额 $0.00 $0.00 -$32.00M -$458.00M -$182.00M
已付现金股利 -$5.00M -$6.00M -$5.00M -$88.00M -$4.00M
其他筹资费用净额 $0.00 -$6.00M -$1.00M -$15.00M -$1.00M
期末现金余额 $1.46B $1.13B $1.12B $574.00M $574.00M
现金净变动 $321.00M $19.00M $573.00M -$251.00M -$111.00M
期初现金余额 $1.13B $1.12B $574.00M $675.00M $672.00M
汇率变动影响 $2.00M -$3.00M -$31.00M $150.00M $13.00M
自由现金流 $326.00M $31.00M $178.00M $384.00M $76.00M

讨论区

暂无评论——快来第一个聊聊 OGN。

登录后参与讨论。

Scroll to Top